What Is Big?
1. Cardiac & Vascular Group: $11.6 Bil (37%)
2. Minimally Invasive Therapies Group: $8.8 Bil (28%)
3. Restorative Therapies Group: $8.6 Bil (27%)
4. Diabetes Group: $2.5 Bil (8%)
--------------------------------------------------------------------------------
Total Expected Revenue 2020: $31.4 Bil
What Has Changed?
From Fiscal 2017 To Fiscal 2020E:
Cardiac & Vascular Group: $1.1 Bil
+ Minimally Invasive Therapies Group: $(1.2) Bil
+ Restorative Therapies Group: $1.2 Bil
+ Diabetes Group: $0.5 Bil
----------------------------------------------------------------------------
Total Revenue Change (2017-2020): $1.7 Bil
+ Medtronic's Revenue In Fiscal 2017: $29.7 Bil
= Total Expected Revenue In Fiscal 2020: $31.4 Bil